Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease
- PMID: 16754804
- DOI: 10.1161/CIRCULATIONAHA.105.570648
Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease
Erratum in
- Circulation. 2006 Aug 22;114(8):e365
Abstract
Background: Contrast-enhanced cardiac magnetic resonance imaging (CMR) can determine the extent of myocardial scar from infarction (MI). However, the prognostic significance of unrecognized myocardial scar by CMR in patients without a history of MI is unknown.
Methods and results: One hundred ninety-five patients without a known prior MI underwent CMR for assessment of left ventricular (LV) function and late gadolinium enhancement (LGE). We assessed the prognostic value of LGE and other CMR variables beyond the strongest clinical predictors and built the best overall models for major adverse cardiac events (MACE) and cardiac mortality. During a median follow-up of 16 months, 31 patients (18%) experienced MACE, including 17 deaths. LGE demonstrated the strongest unadjusted associations with MACE and cardiac mortality (hazard ratios of 8.29 and 10.9, respectively; both P<0.0001). Patients in the lowest tertile of LGE-involved myocardium (mean LV mass, 1.4%) experienced a >7-fold increased risk for MACE. By multivariable analyses, LGE was independently associated with MACE beyond the clinical model (P<0.0001) or the clinical model combined with angiographically significant coronary stenosis (P=0.0007), LV ejection fraction (P=0.001), LV end-systolic volume index (P=0.0006), or segmental WMA (P=0.002). LGE remained the strongest predictor selected in the best overall models for MACE and cardiac mortality.
Conclusions: Among patients with a clinical suspicion of coronary artery disease but without a history of MI, LGE involving a small amount of myocardium carries a high cardiac risk. In addition, LGE provides incremental prognostic value to MACE and cardiac mortality beyond common clinical, angiographic, and functional predictors.
Comment in
-
Does late gadolinium enhancement predict cardiac events in patients with ischemic cardiomyopathy?Circulation. 2006 Jun 13;113(23):2676-8. doi: 10.1161/CIRCULATIONAHA.106.631432. Circulation. 2006. PMID: 16769923 No abstract available.
-
Can cardiac MRI predict outcome in patients at risk for unrecognized myocardial infarction?Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):652-3. doi: 10.1038/ncpcardio0718. Nat Clin Pract Cardiovasc Med. 2006. PMID: 17122796 No abstract available.
Similar articles
-
Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8. Herz. 2008. PMID: 18344033
-
Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.Circulation. 2007 Apr 3;115(13):1769-76. doi: 10.1161/CIRCULATIONAHA.106.652016. Epub 2007 Mar 12. Circulation. 2007. PMID: 17353441 Clinical Trial.
-
Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging.J Am Coll Cardiol. 2009 Nov 3;54(19):1770-7. doi: 10.1016/j.jacc.2009.07.027. J Am Coll Cardiol. 2009. PMID: 19874990
-
Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.Top Magn Reson Imaging. 2008 Feb;19(1):15-24. doi: 10.1097/RMR.0B013e31817d550c. Top Magn Reson Imaging. 2008. PMID: 18690157 Review.
-
Prognostic significance of cardiac magnetic resonance imaging: Update 2010.Cardiol J. 2010;17(6):549-57. Cardiol J. 2010. PMID: 21154256 Review.
Cited by
-
Free-Breathing Motion-Corrected Single-Shot Phase-Sensitive Inversion Recovery Late-Gadolinium-Enhancement Imaging: A Prospective Study of Image Quality in Patients with Hypertrophic Cardiomyopathy.Korean J Radiol. 2021 Jul;22(7):1044-1053. doi: 10.3348/kjr.2020.1296. Epub 2021 Apr 1. Korean J Radiol. 2021. PMID: 33856138 Free PMC article.
-
Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) - a Pan Canadian cohort study.BMC Public Health. 2016 Jul 27;16:650. doi: 10.1186/s12889-016-3310-8. BMC Public Health. 2016. PMID: 27464510 Free PMC article.
-
Noninvasive assessment myocardial viability: current status and future directions.J Nucl Cardiol. 2013 Aug;20(4):618-37; quiz 638-9. doi: 10.1007/s12350-013-9737-8. Epub 2013 Jun 15. J Nucl Cardiol. 2013. PMID: 23771636 Review.
-
Cardiovascular imaging in clinical practice: what does late gadolinium enhance?JAMA. 2013 Mar 6;309(9):929-30. doi: 10.1001/jama.2013.1806. JAMA. 2013. PMID: 23462791 Free PMC article. No abstract available.
-
The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.Curr Cardiol Rep. 2013 Jan;15(1):326. doi: 10.1007/s11886-012-0326-2. Curr Cardiol Rep. 2013. PMID: 23250662 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical